Skip to main content
. 2021 Aug 13;6(2):1–26. doi: 10.20411/pai.v6i2.461

Table 1:

Demographic and clinical information on participants

Participants N=11
Age (median; range) 49 (27-60)
Gender:
 Male (n; %) 8 (72%)
 Female (n; %) 3 (23%)
Race:
 Black (n; %) 10 (91%)
 White (n; %) 1 (9%)
Smoker (n; %) 2 (18%)
CD4 count at entry (median; range) (cells/uL) 529 (172-1062)
CD4 count nadir (median; range) (cells/uL) 129 (24-233)
Duration of ART (median; range) (years) 7(3-13)
Viral load at entry (median; range) (copies/mL) <20 (<20-137)
hsCRP (median; range) (mg/L) 4 (1.6*-9.7)
Total Cholesterol (median; range) (mg/dL) 170 (106-239)
LDL Cholesterol (median; range) (mg/dL) 103 (45-152)
*

One participant fulfilled enrollment criteria of hsCRP ≥ 2mg/dL at screening visit but was below that level at entry